Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition

被引：0

作者：

E. Santana dos Santos

S. M. Caputo

L. Castera

M. Gendrot

A. Briaux

M. Breault

S. Krieger

P. K. Rogan

E. J. Mucaki

L. J. Burke

I. Bièche

C. Houdayer

D. Vaur

D. Stoppa-Lyonnet

M. A. Brown

F. Lallemand

E. Rouleau

机构：

[1] Cancer Institute of the State of São Paulo - ICESP,Department of Oncology, Center for Translational Oncology

[2] Institut Curie,Service de Génétique

[3] CLCC François Baclesse,Laboratoire de Biologie et de Génétique du Cancer

[4] INSERM 1079 Centre Normand de Génomique et de MédecinePersonnalisée,Department of Biochemistry

[5] Schulich School of Medicine and Dentistry,School of Chemistry and Molecular Biosciences

[6] University of Western Ontario,undefined

[7] Université Paris Descartes,undefined

[8] The University of Queensland,undefined

[9] Gustave Roussy,undefined

[10] A.C.Camargo Cancer Center,undefined

来源：

Breast Cancer Research and Treatment | 2018年 / 168卷

关键词：

BRCA1/2 non-coding variants; Hereditary breast and/or ovarian cancer (HBOC); BRCA1/2 transcription regulation; Breast and/or ovarian cancer risk;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：311 / 325

页数：14

共 50 条

[21] Germline mutations in cancer susceptibility genes in BRCA1 and BRCA2 negative families with ovarian and breast cancer
Norquist, B.
Harrell, M.
Walsh, T.
Mandell, J.
Bernards, S.
Agnew, K.
Lee, M.
Pennington, K.
King, M. C.
Swisher, E.
CLINICAL CANCER RESEARCH, 2015, 21
[22] Germline mutations in cancer susceptibility genes in brca1 and brca2 negative families with ovarian and breast cancer
Norquist, B.
Harrell, M.
Walsh, T.
Mandell, J.
Agnew, K.
Lee, M.
Pennington, K.
King, M. C.
Swisher, E.
GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 383 - 383
[23] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
K Claes
B Poppe
I Coene
A De Paepe
L Messiaen
British Journal of Cancer, 2004, 90 : 1244 - 1251
[24] Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families
Papp, J
Raicevic, L
Milasin, J
Dimitrijevic, B
Radulovic, S
Olah, E
ONCOLOGY REPORTS, 1999, 6 (06) : 1435 - 1438
[25] BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families
Claes, K
Poppe, B
Coene, I
De Paepe, A
Messiaen, L
BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1244 - 1251
[26] Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
Yunuo Zhang
Heming Wu
Zhikang Yu
Liang Li
Jinhong Zhang
Xinhong Liang
Qingyan Huang
BMC Cancer, 22
[27] Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
Zhang, Yunuo
Wu, Heming
Yu, Zhikang
Li, Liang
Zhang, Jinhong
Liang, Xinhong
Huang, Qingyan
BMC CANCER, 2022, 22 (01)
[28] Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer
Foulkes, William D.
Polak, Paz
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (12): : 1871 - 1874
[29] Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
Giannini, Giuseppe
Capalbo, Carlo
Ristori, Elisabetta
Ricevuto, Enrico
Sidoni, Tina
Buffone, Amelia
Cortesi, Enrico
Marchetti, Paolo
Scambia, Giovanni
Tomao, Silverio
Rinaldi, Christian
Zani, Massimo
Ferraro, Sergio
Frati, Luigi
Screpanti, Isabella
Gulino, Alberto
BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (01) : 83 - 91
[30] Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
Giuseppe Giannini
Carlo Capalbo
Elisabetta Ristori
Enrico Ricevuto
Tina Sidoni
Amelia Buffone
Enrico Cortesi
Paolo Marchetti
Giovanni Scambia
Silverio Tomao
Christian Rinaldi
Massimo Zani
Sergio Ferraro
Luigi Frati
Isabella Screpanti
Alberto Gulino
Breast Cancer Research and Treatment, 2006, 100 : 83 - 91

← 1 2 3 4 5 →